Catalyst Funds Management’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,500	Closed	-$14.8K	–	1392
2024 Q2	$14.8K	Sell	4,500 -14,300	-76%	-$46.9K	﹤0.01%	790
2024 Q1	$138K	Buy	+18,800	New	+$138K	0.04%	336